LncRNA CBR3-AS1 promotes osteosarcoma progression through the network of miR-140-5p/DDX54-NUCKS1-mTOR signaling pathway
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine
Reference36 articles.
1. Osteosarcoma;Moore;Cancer Treat. Res.,2014
2. Cancer stem cells in osteosarcoma;Brown;Cancer Lett.,2017
3. Update on survival in osteosarcoma;Anderson;Orthop. Clin. North Am.,2016
4. Epidemiology and risk factors of osteosarcoma;Sadykova;Cancer Invest.,2020
5. On the biomechanical properties of osteosarcoma cells and their environment;Müller;Int. J. Dev. Biol.,2019
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Genetic variation perspective reveals potential drug targets for subtypes of endometrial cancer;2024-07-03
2. Allicin affects immunoreactivity of osteosarcoma cells through lncRNA CBR3-AS1;Heliyon;2024-06
3. Emerging roles of long non-coding RNAs in osteosarcoma;Frontiers in Molecular Biosciences;2024-03-07
4. Highly Aggressive Osteosarcoma of the Ethmoids and Maxillary Sinus-A Case of Successful Surgery and Proton Beam Radiotherapy in a 65-Year-Old Man;Medicina;2022-08-23
5. LncRNA SCAMP1 disrupts the balance between miR-26a-5p and ZEB2 to promote osteosarcoma cell viability and invasion;Frontiers in Oncology;2022-08-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3